DCF — PARIS REGIONAL MEDICAL CENTER
Enterprise Value: $39.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$39.7M
Enterprise Value
$8.3M
PV of Cash Flows
$31.4M
PV of Terminal Value
$50.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $134.9M | $7.2M | 5.0% | $0.5M | $0.5M |
| Year 2 | $139.0M | $8.8M | 6.0% | $1.6M | $1.3M |
| Year 3 | $143.2M | $10.5M | 7.0% | $2.7M | $2.0M |
| Year 4 | $147.5M | $11.5M | 8.0% | $3.3M | $2.3M |
| Year 5 | $151.9M | $12.2M | 8.0% | $3.7M | $2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $39.7M. Terminal value accounts for 79% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$131.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.048066454665544864
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5